Júlio Maria Fonseca Chebli

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Bruce E. Sands, Peter M. Irving, Timothy Hoops et al. · The Lancet · 2022 · 297 citations · Full text

Medicine, Clinical Sciences, Immunology +17

A Full Solid Diet as the Initial Meal in Mild Acute Pancreatitis is Safe and Result in a Shorter Length of Hospitalization

José Maria Mendes Moraes, Guilherme Eduardo Gonçalves Felga, Liliana Andrade Chebli et al. · Journal of Clinical Gastroenterology · 2010 · 123 citations

Agriculture, Nutrition, Nutritional Sciences +12

Physical Activity in Hemodialysis Patients Measured by Triaxial Accelerometer

Edimar Pedrosa Gomes, Maycon Moura Reboredo, Erich Vidal Carvalho et al. · BioMed Research International · 2015 · 89 citations · Full text

Education, Health Behavior, Nephrology +15

Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil

Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Heda M B S Amarante et al. · World Journal of Gastroenterology · 2019 · 87 citations · Full text

Medicine, Health Sciences, Gastroenterology +13

Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis†

Liliana Andrade Chebli, Leonardo Duque de Miranda Chaves, Felipe Ferreira Pimentel et al. · Inflammatory Bowel Diseases · 2009 · 83 citations

Pharmacy, Immunology, Pharmacotherapy +16